Next 10 |
SALT LAKE CITY, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD ) , a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company has filed a U.S. provisional pa...
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD) , a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (...
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD) , a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trade...
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company is closely monitoring two new clinical trials t...
SALT LAKE CITY, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), National Investment Bankers Association (NIBA) presenter Nu-Med Plus, Inc., a medical device development company announced that a patent has been filed for a nitric oxide delivery device that is designed ...
SALT LAKE CITY, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), announced today that the Company attended and presented at the 147th National Investment Banking Association (NIBA) conference scheduled for November 12-13, 2019 at the Westin Times Square Hotel in New Yo...
SALT LAKE CITY, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the medical field, announces the production version of the nitric oxide delivery device for us...
SALT LAKE CITY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device developer of new nitric oxide delivery technology announced that it will be accelerating the FDA submission of its hospital ICU focused nitric oxide delivery device considering the recen...
SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology along with innovative applications in the medical field, announces the engagement of Christina Thomas as a strategic regulatory serv...
SALT LAKE CITY, April 03, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, reports an increase in strategic partnership, physician and researcher inquiries, and licensing opportunities. The international i...
News, Short Squeeze, Breakout and More Instantly...
SALT LAKE CITY, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD ) , a medical device company which investigates and develops applications and devices for nitric oxide in the medical field, today announced that the Company has filed a U.S. provisional pa...
SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD) , a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (...
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD) , a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trade...